National Health Investors, Inc. (NYSE:NHI – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven brokerages that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $73.29.
Several research firms have recently weighed in on NHI. Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price objective for the stock from $81.00 to $86.00 in a research report on Tuesday. StockNews.com upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Thursday, August 8th. Bank of America assumed coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target on the stock. Finally, Truist Financial lifted their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th.
View Our Latest Research Report on NHI
Institutional Trading of National Health Investors
National Health Investors Stock Performance
NYSE:NHI opened at $81.63 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27. National Health Investors has a fifty-two week low of $48.51 and a fifty-two week high of $86.13. The company has a 50 day simple moving average of $79.37 and a two-hundred day simple moving average of $70.20. The company has a market capitalization of $3.54 billion, a PE ratio of 26.70, a P/E/G ratio of 8.86 and a beta of 1.04.
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The firm had revenue of $84.97 million for the quarter, compared to analyst estimates of $64.95 million. During the same quarter last year, the company earned $1.06 earnings per share. The company’s quarterly revenue was up 9.1% compared to the same quarter last year. Research analysts anticipate that National Health Investors will post 4.55 earnings per share for the current year.
National Health Investors Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, September 27th will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.41%. The ex-dividend date is Friday, September 27th. National Health Investors’s dividend payout ratio is currently 118.03%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- The Significance of Brokerage Rankings in Stock Selection
- When Is the Best Time to Invest in Mutual Funds?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Is NVIDIA Stock in a Correction or Consolidation?
- How to Invest in Insurance Companies: A GuideĀ
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.